Modification of Corneal Biomechanics and Intraocular Pressure Following Non-Penetrating Deep Sclerectomy [PDF]
Changes in the cornea can influence outcomes in patients with primary open-angle glaucoma (POAG). We aimed to evaluate the relevance of changes in corneal biomechanics and intraocular pressure (IOP) in patients undergoing non-penetrating deep sclerectomy (NPDS) with the Esnoper V2000 implant® (AJL Ophthalmic S.A., Gasteiz, Spain).
Boned-Murillo A +2 more
exaly +8 more sources
Results of a modified non-penetrating deep sclerectomy in the treatment of open angle glaucoma with or without cataract [PDF]
George Kitsos1, Miltiades Aspiotis1, Yannis Alamanos2, Konstantinos Psilas11Department of Ophthalmology, Medical School, University of Ioannina, Ioannina, Greece; 2Department of Hygiene and Epidemiology, Medical School, University of Patras, Patras ...
George Kitsos +3 more
doaj +10 more sources
Non-Penetrating Deep Sclerectomy versus Trabeculectomy in Primary Congenital Glaucoma [PDF]
Abdelhamid Elhofi, Hany Ahmed Helaly Ophthalmology Department, Faculty of Medicine, Alexandria University, Alexandria, EgyptCorrespondence: Hany Ahmed Helaly 30 Roshdy Street, Roshdy, Alexandria, EgyptTel +20 1225466733Email hany209209@yahoo.comPurpose ...
Elhofi A, Helaly HA
doaj +5 more sources
Refractive astigmatism in phaco-canaloplasty vs phaco-non-penetrating deep sclerectomy [PDF]
This study aimed to assess refractive astigmatism, in phaco-canaloplasty (PC) vs phaco-non-penetrating deep sclerectomy (PDS) in a randomized, prospective study within 24 months. Patients were randomized pre-operatively, 37 underwent PC and 38 PDS.
Anna Byszewska +4 more
doaj +4 more sources
Long-Term Outcomes of Combined Phacoemulsification and Non-Penetrating Deep Sclerectomy versus Standalone Non-Penetrating Deep Sclerectomy [PDF]
Khaled Safadi,1 Gustavo Adolfo Gutierrez Vargas,1 Yaacov Cnaany,1 Shoham Kubovsky,1 Wiessam Abu Ahmad,2,3 Gabriel Greifner1 1Department of Ophthalmology, Hadassah University Medical Center, Jerusalem, Israel; 2Braun School of Public Health, The Hebrew ...
Safadi K +5 more
doaj +3 more sources
Plasma Rich in Growth Factors as an Adjuvant Agent in Non-Penetrating Deep Sclerectomy [PDF]
Background: The purpose of this study is to evaluate the utility and safety of plasma rich in growth factors immunosafe eye drops (is-ePRGF) in the postoperative treatment of non-penetrating deep sclerectomy (NPDS). Methods: This is a case–control study in patients with open-angle glaucoma. Group one (control) was not treated with is-ePRGF, while group
Pedro P. Rodríguez-Calvo +5 more
openaire +4 more sources
Combined Trabeculotomy-Non-Penetrating Deep Sclerectomy for Glaucoma in Sturge-Weber Syndrome
Introduction: The aim of the study was to evaluate the efficacy and safety of combined trabeculotomy-non-penetrating deep sclerectomy (CTNS) in the treatment of Sturge-Weber syndrome (SWS) secondary glaucoma. Methods: This retrospective study reviewed cases that underwent CTNS as initial surgery for SWS secondary glaucoma at our Ophthalmology ...
Lulu Huang +8 more
openaire +3 more sources
Non-penetrating deep sclerectomy versus combined trabeculotomy–trabeculectomy in primary congenital glaucoma [PDF]
Background: The primary mode of therapy in children with primary congenital glaucoma (PCG) and mild or no corneal edema is goniotomy, which has a high success rate. However, in developing countries, the diagnosis of PCG is usually delayed, and corneal cloudiness interferes with goniotomy. Therefore, trabeculotomy may be the best choice in such eyes. We
Elabd, Ibrahim Hassan +15 more
openaire +3 more sources
Aim. To analyze the effect of dosed endotrabeculectomy in combination with non-penetrating deep sclerectomy on the level of intraocular pressure (IOP) and aqueous humor outflow from the anterior chamber. Materials and methods.
O. V. Levytska, I. Ya. Novytskyy
doaj +3 more sources
Changes in ocular surface after withdrawal of anti-glaucoma medications following non-penetrating deep sclerectomy [PDF]
Purpose: To analyze the ocular surface changes in eyes after the withdrawal of anti-glaucomatous drugs when non-penetrating deep sclerectomy (NPDS) is performed.
Carlota Fuente-García +4 more
doaj +2 more sources

